【直报网6月11日讯】（证券时报网）康恩贝晚间发布公告称，经自查，公司下属子公司云南希陶绿色药业股份有限公司附属安宁分公司违反公司有关规定，于2014年10月至2015年4月期间从云南白药（000538）集团中药资源有限公司购进并销售银杏叶提取物合计6.9吨。

CNDSN June 11 news] (net of negotiable securities times) Conba evening announcement said, through self-examination, a subsidiary company of subsidiary of Yunnan Xitao green Pharmaceutical Co., Ltd. affiliated peace branch, in violation of the relevant provisions of the company, in October 2014 to 2015 during April from Yunnan Baiyao (000538) group of traditional Chinese Medicine Resources Co., Ltd. purchase and sales of Ginkgo biloba extract a total of 690 tons.

对此康恩贝要求相关子公司根据各级食药监部门有关通知精神对该批问题银杏叶提取物的销售、使用情况进行排查并及时通知和协调有关企业采取有效的控制措施。根据云南白药有关公告进一步核查确认，该批问题银杏叶提取物系来源于桂林兴达药业有限公司。

This Conba requirements and related subsidiaries according to the levels of the food and drug administration department to inform the relevant spirit on the issue of Ginkgo biloba extract sales, use investigation and promptly notify and coordinate with the relevant enterprises to adopt effective control measures. According to the announcement on the Yunnan Baiyao further verification confirmed that the number of Ginkgo biloba extract line derived from Guilin Xingda Pharmaceutical Co., Ltd..

2015年5月19日，国家食品药品监督管理局发布了《关于桂林兴达药业有限公司等企业违法生产销售银杏叶药品的通告》，有24家药品生产企业从桂林兴达药业有限公司购买非法银杏叶提取物，其中涉及云南白药集团中药资源公司。

May 19, 2015, the State Food and Drug Administration issued "the notice of a Guilin Xingda Pharmaceutical Co., Ltd. and other enterprises illegal production and sales of Ginkgo biloba leaf drug", 24 drug production enterprises from Guilin Xingda Pharmaceutical Co., Ltd. to buy illegal ginkgo leaf extract, which involves Yunnan Baiyao group of Chinese medicine resources.

云南白药5月26日公告显示，中药资源公司的下游客户云南希陶绿色药业股份有限公司安宁分公司，从具备银杏叶提取物生产资质的桂林兴达采购五批计 6.9 吨银杏叶提取物，并销售给云南希陶绿色药业股份有限公司安宁分公司，目前货物已全部发往云南希陶绿色药业股份有限公司安宁分公司。该行为系中药资源公司正常的经营贸易业务。除以上业务外，中药资源公司未发生过任何银杏叶提取物的生产、采购和销售业务。

Yunnan Baiyao on May 26 announcement shows that traditional Chinese medicine resources downstream customers Yunnan Xitao green Pharmaceutical Co., Ltd. Anning Branch, from Ginkgo biloba extract production qualification Guilin Xingda purchase batch of 5 meter 6.9 tons of Ginkgo biloba extract, and sales to the branch of Yunnan Xi Tao green Pharmaceutical Co., Ltd. peace. At present, the goods have been developed to the Yunnan Xitao green Pharmaceutical Co., Ltd. Anning Branch. The behavior Department of Chinese medicine resources company normal business and business. In addition to the above business, the Chinese herbal resources company has not occurred any Ginkgo biloba extract production, procurement and sales business.

据云南希陶安宁分公司报告，截至目前，上述6.9吨问题银杏叶提取物中，已有95.65%的产品得到有效控制和召回(以提取物计合计6.6吨)，剩余问题银杏叶产品正在积极召回中。▲

According to Yunnan Xitao peace sub company report, as of now, the 6.9 tons of ginkgo leaf extract and existing 95.65% of the products get effective control and recall (to extract meter total 6.6 tons), the remaining problems of Ginkgo biloba products are actively recall. 3

（原标题：康恩贝：子公司购进销售问题银杏叶提取物）

(original title: Conba: subsidiary purchased sales of Ginkgo biloba extract)

责任编辑：婉婉

Editor: Wan Wan